Vilanova I La Geltru

Researchers are evaluating whether an interactive and informative exhibition in the waiting room of a primary care clinic can reduce benzodiazepine use among adults. The study focuses on adults aged 18 to 99 who attend the Baix-a-Mar Primary Care Center. The main question is whether this exhibition can decrease the number of participants using benzodiazepines by comparing usage before and after the exhibition is introduced. The intervention includes setting up an interactive exhibition about the risks of long-term benzodiazepine use in the clinic's waiting area. Additionally, health professionals at the center will attend a single informative session on the same topic. This combined approach aims to educate both patients and providers about benzodiazepine risks. Participants will be monitored for one year to assess their benzodiazepine use during this period. Researchers will track changes in medication consumption and evaluate the impact of the exhibition on deprescribing benzodiazepines. The study involves adults who regularly attend the primary care center and includes assessments of medication use over time.

Researchers are studying cognitive performance in people over 80 years old who live outside of institutions. They aim to establish normal ranges for 18 common neuropsychological tests used in Memory Clinics, as current tests may not be well-suited for this oldest-old population. The study will help improve how cognitive abilities are assessed in this age group. The study will enroll 120 participants aged 80 and older, divided into four age groups: 80-84, 85-89, 90-94, and 95 or older. Participants will be randomly selected from five Primary Care Centers in the Comarca del Garraf region. Each person will complete 18 neuropsychological tests, with results adjusted for age and education level. Participants will visit the Memory Clinic Unit for cognitive testing, which lasts about 60 minutes. Researchers will measure cognitive performance using the test scores and define normal limits based on percentiles. The study excludes people with severe mental illness, recent hospitalizations, major neurological diseases, or dementia. This study focuses on people who can read and write sufficiently and are able to travel to the study site.

Researchers are evaluating the safety of remote consultations, including video and telephone visits, compared to traditional face-to-face consultations for patients with various clinical conditions usually followed in a secondary hospital. This randomized controlled trial aims to determine if remote consultations result in a similar frequency of complications of the underlying disease over a 12-month period, including any adverse reactions to treatment. The study includes adults and children who can participate in remote follow-up without requiring physical examinations and who have the necessary technology and skills for video consultations. Participants will be randomly assigned to one of three groups: the control group with face-to-face appointments, or one of two remote consultation groups using telephone or video calls. In the control group, face-to-face visits are the standard, with limited phone call interactions allowed. For remote consultations, patients will receive reminders and will either wait for a scheduled phone call or join a virtual waiting room for video calls. Physicians will schedule at least three visits, including a baseline screening visit, intermediate visits based on patient needs, and a final visit around 12 months after enrollment or sooner if necessary. During the study, participants will be regularly evaluated through these scheduled visits, and physicians can adjust appointments as needed. The main outcome measured is the occurrence of disease complications within 12 months. Researchers will track safety through monitoring complications and adherence to the assigned consultation method. The study will analyze results from participants who complete the study as planned without unapproved changes in consultation modes.